國(guo)(guo)(guo)藥(yao)(yao)(yao)(yao)(yao)(yao)集(ji)團(tuan)(tuan)(tuan)一(yi)致(zhi)(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)業股(gu)(gu)份有限(xian)公(gong)(gong)司(簡稱國(guo)(guo)(guo)藥(yao)(yao)(yao)(yao)(yao)(yao)一(yi)致(zhi)(zhi))國(guo)(guo)(guo)藥(yao)(yao)(yao)(yao)(yao)(yao)集(ji)團(tuan)(tuan)(tuan)一(yi)致(zhi)(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)業股(gu)(gu)份有限(xian)公(gong)(gong)司 (簡稱國(guo)(guo)(guo)藥(yao)(yao)(yao)(yao)(yao)(yao)一(yi)致(zhi)(zhi))是中(zhong)國(guo)(guo)(guo)醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)集(ji)團(tuan)(tuan)(tuan)有限(xian)公(gong)(gong)司、國(guo)(guo)(guo)藥(yao)(yao)(yao)(yao)(yao)(yao)控股(gu)(gu)股(gu)(gu)份有限(xian)公(gong)(gong)司旗下綜合性醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)上(shang)市公(gong)(gong)司(A股(gu)(gu)000028,B股(gu)(gu)200028),是國(guo)(guo)(guo)藥(yao)(yao)(yao)(yao)(yao)(yao)集(ji)團(tuan)(tuan)(tuan)全國(guo)(guo)(guo)醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)零(ling)售(shou)整合平(ping)臺,業務涵蓋“藥(yao)(yao)(yao)(yao)(yao)(yao)品分銷+醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)物流+醫(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)零(ling)售(shou)+工業投資(zi)”全產(chan)業鏈條,下屬子(zi)公(gong)(gong)司達到110家,員工30000多人。承擔(dan)著(zhu)中(zhong)央、省(廣東(dong)、廣西)、市(廣州、深(shen)圳(zhen)、南寧(ning)等(deng))藥(yao)(yao)(yao)(yao)(yao)(yao)械商品特種儲備及全國(guo)(guo)(guo)各(ge)地(di)所(suo)需搶險救災藥(yao)(yao)(yao)(yao)(yao)(yao)品調撥和供(gong)應(ying)任務。
國(guo)(guo)藥(yao)一致在(zai)藥(yao)品分銷領域,立足于打(da)造“卓越的(de)醫療(liao)供(gong)(gong)應(ying)鏈解(jie)決方案及(ji)服(fu)務提供(gong)(gong)商(shang)”,以集(ji)成化、規模化的(de)產業優勢,在(zai)中(zhong)(zhong)(zhong)國(guo)(guo)南區形成強(qiang)大的(de)商(shang)業網絡(luo)(luo)。截(jie)止目前,公司(si)(si)在(zai)廣州、深圳、佛山、東莞、等(deng)兩(liang)廣重湛江、梅州、惠州、肇慶、江門、韶關、中(zhong)(zhong)(zhong)山、南寧、柳州要(yao)區域擁有(you)47家子公司(si)(si),實現(xian)(xian)在(zai)中(zhong)(zhong)(zhong)國(guo)(guo)南區的(de)深度滲透(tou)。公司(si)(si)構建(jian)起由(you)區域物流(liu)(liu)中(zhong)(zhong)(zhong)心(xin)(xin)、省級(ji)物流(liu)(liu)中(zhong)(zhong)(zhong)心(xin)(xin)、城(cheng)市配(pei)(pei)送中(zhong)(zhong)(zhong)心(xin)(xin)及(ji)配(pei)(pei)送站組成的(de)“四位一體”階梯(ti)式物流(liu)(liu)配(pei)(pei)送網絡(luo)(luo),拓(tuo)展(zhan)多倉運(yun)營、第三方物流(liu)(liu)、冷(leng)鏈管(guan)(guan)理(li)等(deng)現(xian)(xian)代物流(liu)(liu)運(yun)作的(de)新模式,為客(ke)戶及(ji)供(gong)(gong)應(ying)商(shang)提供(gong)(gong)有(you)效(xiao)、快捷的(de)藥(yao)品配(pei)(pei)送及(ji)物流(liu)(liu)增值服(fu)務。此(ci)外,公司(si)(si)還積(ji)極推(tui)動業務轉型升級(ji),著力推(tui)進全國(guo)(guo)零售終端業務,打(da)造全國(guo)(guo)零售直銷商(shang)業平臺。采用先進的(de)供(gong)(gong)應(ying)鏈管(guan)(guan)理(li)方法和(he)現(xian)(xian)代技(ji)術,開(kai)展(zhan)器械業務,拓(tuo)展(zhan)4D業務,打(da)造SPD核心(xin)(xin)競(jing)爭(zheng)力,攜(xie)手醫療(liao)機構開(kai)展(zhan)供(gong)(gong)應(ying)鏈管(guan)(guan)理(li)延伸,實現(xian)(xian)降費增效(xiao)。2019年底,分銷銷售收入超400億(yi)。
國(guo)藥(yao)(yao)一致在藥(yao)(yao)品零售(shou)(shou)領域,攜手(shou)(shou)全(quan)球以藥(yao)(yao)店(dian)為主導的(de)(de)(de)世界醫(yi)(yi)藥(yao)(yao)保健(jian)企業(ye)沃(wo)博聯,打造(zao)消費者放心的(de)(de)(de)中國(guo)醫(yi)(yi)藥(yao)(yao)健(jian)康零售(shou)(shou)品牌(pai)“國(guo)大藥(yao)(yao)房”。目前,已在全(quan)國(guo)21個(ge)省、自治區、直轄市(shi)建立了27家(jia)區域連鎖公(gong)司(si),覆蓋全(quan)國(guo)75各地(di)級城市(shi),擁有超(chao)過5000家(jia)零售(shou)(shou)藥(yao)(yao)店(dian)。六年(nian)來穩居(ju)中國(guo)醫(yi)(yi)藥(yao)(yao)零售(shou)(shou)行業(ye)首位。依托先(xian)進的(de)(de)(de)管(guan)理能(neng)力(li)、有效(xiao)(xiao)快捷的(de)(de)(de)采購體(ti)系(xi)、嚴格的(de)(de)(de)質量管(guan)控(kong)、精細的(de)(de)(de)門(men)店(dian)管(guan)理、貼心的(de)(de)(de)慢病服務、有效(xiao)(xiao)的(de)(de)(de)物流體(ti)系(xi)、全(quan)國(guo)ERP平臺等一系(xi)列優勢(shi),局涵蓋中藥(yao)(yao)、西(xi)藥(yao)(yao)、中醫(yi)(yi)、西(xi)醫(yi)(yi)、康復理療與各類(lei)醫(yi)(yi)療相關(guan)資源的(de)(de)(de)零售(shou)(shou)診療門(men)店(dian),創新應(ying)用(yong)“互聯網+”技術(shu),攜手(shou)(shou)各地(di)政府開展在線社區健(jian)康建設,保障(zhang)人(ren)民健(jian)康需求。2019年(nian),國(guo)大藥(yao)(yao)房銷(xiao)售(shou)(shou)收入超(chao)120億元。
國(guo)藥(yao)(yao)一致(zhi)(zhi)工(gong)(gong)業投(tou)資戰略主要參股工(gong)(gong)業企業國(guo)藥(yao)(yao)致(zhi)(zhi)君(jun)深圳(zhen)(zhen)制(zhi)藥(yao)(yao)有限(xian)公(gong)(gong)司(si)(si)、國(guo)藥(yao)(yao)致(zhi)(zhi)君(jun)深圳(zhen)(zhen)坪山(shan)制(zhi)藥(yao)(yao)有限(xian)公(gong)(gong)司(si)(si)、深圳(zhen)(zhen)致(zhi)(zhi)君(jun)醫藥(yao)(yao)貿(mao)易有限(xian)公(gong)(gong)司(si)(si)、深圳(zhen)(zhen)萬樂藥(yao)(yao)業有限(xian)公(gong)(gong)司(si)(si),覆(fu)蓋(gai)抗感染、呼吸系(xi)統用(yong)藥(yao)(yao)、保健品、中(zhong)成藥(yao)(yao)及抗腫瘤藥(yao)(yao)等領域(yu)的研發、生產及銷售。2019年,工(gong)(gong)業投(tou)資板塊銷售額超(chao)40億(yi)元(yuan)。
未來,國(guo)(guo)藥一致將(jiang)繼續秉(bing)承“關(guan)愛生(sheng)命 呵(he)護健(jian)康”的理(li)念,立足中國(guo)(guo)醫(yi)藥健(jian)康產(chan)業發(fa)展(zhan)機遇,轉型創新,深度(du)發(fa)揮(hui)分銷和(he)(he)零售(shou)資源協(xie)同效應,推進(jin)批零一體戰(zhan)略和(he)(he)國(guo)(guo)際(ji)化戰(zhan)略,以(yi)科技創新推進(jin)公司數(shu)字化轉型,向著(zhu)國(guo)(guo)際(ji)化醫(yi)藥健(jian)康服務平臺(tai)和(he)(he)更(geng)高(gao)規(gui)模目標邁(mai)進(jin)!